// App-Quantinova.ai

T4257 2015 AHA : Is There Any End in Sight to This Debate on the Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Coronary Stent Implantation?

Researchers

Presenter

  • Xavier Perez

Principal Investigators

  • Bredy Pierre-Louis

  • Damian Kurian

  • Rene R Packard

Medical Centers

  • Harlem Hosp Ctr, Columbia Univ Medical Ctr, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved